Mazdutide.

Mazdutide is a dual GLP-1/glucagon receptor agonist with a lipid side chain. With the molecular formula C₂₀₅H₃₁₅N₅₁O₆₆ and a molecular weight of 4525.0 g/mol (CAS: 2496030-49-4), it presents a well-ch...

$68.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for Mazdutide.

Receptor interaction

GLP-1 Receptor

Published research demonstrates Mazdutide modulates targeted signaling cascades within cell tissue models.

Signaling cascade

Glucagon Receptor (GCGR)

In cellular environments, Mazdutide exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on Mazdutide molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of Mazdutide in standardized assay systems.

Preclinical

Mazdutide structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of Mazdutide in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring